Form 8-K - Current report:
SEC Accession No. 0001564590-21-043428
Filing Date
2021-08-11
Accepted
2021-08-11 16:07:22
Documents
5
Period of Report
2021-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20210811.htm 8-K 39592
2 EX-99.1 cccc-ex991_51.htm EX-99.1 150981
3 EX-99.2 cccc-ex992_19.htm EX-99.2 15384
4 GRAPHIC gv4ezyt450v4000001.jpg GRAPHIC 7489
5 GRAPHIC gihczet2asjy000001.jpg GRAPHIC 7489
  Complete submission text file 0001564590-21-043428.txt   228097
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 211163464
SIC: 2836 Biological Products, (No Diagnostic Substances)